Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer.
Hadadi A, Smith KE, Wan L, Brown JR, Russler G, Yantorni L, Caulfield S, Lafollette J, Moore M, Kucuk O, Carthon B, Nazha B, Liu Y, Bilen MA.
Hadadi A, et al. Among authors: lafollette j.
Urol Oncol. 2022 Jun;40(6):271.e9-271.e18. doi: 10.1016/j.urolonc.2022.03.016. Epub 2022 Apr 22.
Urol Oncol. 2022.
PMID: 35466038
Free PMC article.